Tag: TP53

Oncotarget News

Researchers Identify New p53 Targets to Combat Cancer Growth

February 24, 2025

We discovered several novel downstream p53 targets of potential clinical relevance [...]”BUFFALO, NY - February 24, 2025 – A new research paper was published in Oncotarget, Volume 16, on February 18, 2025,... read more

Figure 4: Everolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts.

Oncotarget

Oncotarget | Everolimus Inhibits Angiogenesis and Lymphangiogenesis in TP53 Mutant HNSCC by Downregulating STAT3/HIF-1α/VEGF Pathway

February 9, 2023

we sought to investigate the mechanism for everolimus-induced inhibition of TP53 HNSCC.” BUFFALO, NY- February 9, 2023 – A new research paper was published in Oncotarget's Volume 14 on February... read more